11/05/2019
Remozen 100mg tablet
remogliflozin etabonate 100mg
The drug, generically called as Remogliflozin etabonate, is used in the treatment of type-2 diabetes mellitus in adults.
Glenmark Pharmaceuticals on April 30 launched a novel and patented anti-diabetes drug belonging to the class of sodium glucose co-transporter-2 (SGLT2) inhibitor, which is said to be 50-60 percent cheaper than the existing medications of same class in the market.
The drug, generically called as Remogliflozin etabonate, is used in the treatment of type-2 diabetes mellitus in adults and was approved by Indian drug regulator CDSCO in March this year. India is the first country where the drug will be sold.
MedizKart...